Nanotechnology as a therapeutic tool to combat microbial resistance
We conducted descriptive and comparative analyses to explore mortality, latency to onset, the relationship between prior drug-allergy history and SJS/TEN phenotype and mortality, and the characteristics and classification of implicated drugs, thereby providing preliminary insights into the clinical features and potential immunologic mechanisms underlying concurrent DILI and SJS/TEN
Efficacy and safety of cotadutide, a dual glucagon-like peptide-1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease
Some references describe broader ranges like ~15 mg/day depending on the goal and tolerance
This distinguishes it from better-known compounds such as semaglutide (Ozempic/Wegovy), which targets only the GLP-1 receptor, and from tirzepatide (Mounjaro/Zepbound), which is a dual GLP-1/GIP agonist
The role of calcium in wound healing
